Systematic review of 10 RCTs (5 meta-analysed; 2235 vs 1409 patients) in elderly patients with chronic insomnia: dual orexin receptor antagonists improved sleep latency, wake after sleep onset and total sleep time vs placebo; lemborexant and suvorexant had more adverse events.
Meta-analysisn = 3,644
Rollo et al. Treatment of chronic insomnia in elderly adults with dual orexin receptor antagonists: a systematic review and meta-analysis